Obtained Dismissal of All Claims Brought Against Diagnostic Testing Provider in Patent Litigation Relating to Genetic Tests Used to Detect Hereditary Cancer

March 9, 2015

In re: BRCA1- and BRCA2-Based Hereditary Cancer Test Patent Litigation, No. 2:14-MD-02510-RJS (D. Utah)

Robins Kaplan LLP represented Quest Diagnostics in multi-district patent infringement litigation involving Myriad Genetics’ patents for genetic-based tests to detect genes linked to hereditary cancer. The firm obtained dismissal of all claims.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Jamie R. Kurtz


Co-Chair, Health Care Litigation Group

Similar Results

Back to Top